Survival activity of troglitazone in rat motoneurones

Journal of Neurochemistry

Volumn 76, Issue 2, 2001, Pages 383-390

  Nishijima, Chiaki ^a   Kimoto, Kosuke ^a   Arakawa, Yoshihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Culture; Insulin like growth factors; Neurotrophic; Phosphatidylinositol 3 kinase; Thiazolidinedione

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 6 HYDROXY 2,2,5,7,8 PENTAMETHYLCHROMAN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL KINASE; PIOGLITAZONE; RILUZOLE; SOMATOMEDIN C; TROGLITAZONE; WORTMANNIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HIPPOCAMPUS; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; NERVE CELL CULTURE; NONHUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CHROMANS; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR I; MOTOR NEURONS; NEURONS, AFFERENT; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEPTUM OF BRAIN; SPINAL CORD; SYMPATHETIC NERVOUS SYSTEM; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0035142007     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00039.x     Document Type: Article

References (67)

1. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
2. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
3. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines
4. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells
5. A controlled trial of recombinant methionyl human BDNF in ALS
6. Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum
7. A controlled trial of riluzole in amyotrophic lateral sclerosis
8. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
9. Amyotrophic lateral sclerosis. Insights from genetics
10. Purification of embryonic rat motoneurons by panning on a monoclonal antibody to the low-affinity NGF receptor
11. p75 neurotrophin receptor as a modulator of survival and death decisions
12. p75 and Trk: A two-receptor system
13. Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects
14. The expression of adhesion molecules on endothelial cells is inhibited by troglitazone through its antioxidant activity
15. Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice
16. The survival of sympathetic neurons promoted by potassium depolarization, but not by cyclic AMP, requires phosphatidylinositol 3-kinase and Akt
17. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Involvement of PI 3-kinase in IGF-1 signaling
18. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism
19. Thiazolidinediones: A new class of antidiabetic drugs
20. Sulfonylurea-sensitive K (+) channels and their probable role for the membrane potential of mouse motor nerve endings
21. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase
22. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival
23. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
24. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves
25. Motoneuron survival factors: Biological roles and therapeutic potential
26. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
27. Neurotrophin signaling
28. Insulin signaling in the arterial wall
29. Neurotrophic factors and the development of drugs to promote motoneuron survival
30. On the therapeutic potential for insulin-like growth factor use in motor neuron disease
31. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism
32. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
33. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve
34. Troglitazone inhibits the capacitative Ca2+ entry in endothelial cells
35. Amyotrophic lateral sclerosis: The involvement of intracellular Ca2+ and protein kinase C
36. Dose-ranging study of riluzole in amyotrophic lateral sclerosis
37. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study
38. Troglitazone inhibits type 2 K (ATP) channel activity and depolarizes tolbutamide-sensitive neurons in the rat ventromedial hypothalamus
39. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
40. Insulin-like growth factor-I: Potential for treatment of motor neuronal disorders
41. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
42. Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases
43. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotropbic lateral sclerosis and normal individuals
44. Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis
45. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells
46. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K (+) current in rat aorta myocytes
47. Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes
48. Signaling pathways and survival effects of BDNF and NT-3 on cultured cerebellar granule cells
49. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro
50. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma
51. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial)
52. Hypoxic response of hypoglosssal motoneurons in the in vivo cat
53. Differential spatiotemporal expression of the insulin-like growth factor genes in regenerating sciatic nerve
54. Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy
55. Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
56. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
57. Actions of CNTF and neurotrophins on degenerating motoneurons: Preclinical studies and clinical implications
58. Structure and function of the insulin-like growth factor I receptor
59. Involvement of phosphatidylinositol-3 kinase in prevention of low K (+)-induced apoptosis of cerebellar granule neurons
60. Troglitazone but not pioglitazone affects ATP-sensitive K (+) channel activity
61. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter
62. Nerve growth factor-induced PKB/Akt activity is sustained by phosphoinositide 3-kinase dependent and independent signals in sympathetic neurons
63. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
64. The genetic and molecular mechanisms of motor neuron disease
65. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons
66. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
67. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes